Lymphopenia in COVID‐19: Therapeutic opportunities
Sign Up to like & getrecommendations! Published in 2020 at "Cell Biology International"
DOI: 10.1002/cbin.11403
Abstract: Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is uncontrollably spread all over the world. The host immune responses strongly try to confront it with all the potential cells and cytokines. With chronically condition of… read more here.
Keywords: therapeutic opportunities; covid therapeutic; lymphopenia covid;
Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
Sign Up to like & getrecommendations! Published in 2020 at "Cellular and Molecular Immunology"
DOI: 10.1038/s41423-020-0484-x
Abstract: Since the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 6 million cases are confirmed and over 300,000 cases are dead after infection. Dysfunction of immunity… read more here.
Keywords: covid patients; lymphopenia covid; covid; fig ... See more keywords
The putative mechanism of lymphopenia in COVID-19 patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Molecular Cell Biology"
DOI: 10.1093/jmcb/mjac034
Abstract: 1 Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China 2 Department of Infectious Diseases and Shenzhen Key Lab of Endogenous… read more here.
Keywords: lymphopenia covid; putative mechanism; covid patients; virology ... See more keywords